DK174878B1 - Anvendelse af N-aryl-piperazinalkanamidderivater til fremstilling af et medikament til forbedring af søvn - Google Patents

Anvendelse af N-aryl-piperazinalkanamidderivater til fremstilling af et medikament til forbedring af søvn Download PDF

Info

Publication number
DK174878B1
DK174878B1 DK198801797A DK179788A DK174878B1 DK 174878 B1 DK174878 B1 DK 174878B1 DK 198801797 A DK198801797 A DK 198801797A DK 179788 A DK179788 A DK 179788A DK 174878 B1 DK174878 B1 DK 174878B1
Authority
DK
Denmark
Prior art keywords
alkyl
aminocarbonyl
aryl
mono
6alkyl
Prior art date
Application number
DK198801797A
Other languages
Danish (da)
English (en)
Other versions
DK179788A (da
DK179788D0 (da
Inventor
Marc Gustaaf Celine Verdonck
Freddy Francois Vlaeminck
Georges Henri Paul Van Daele
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of DK179788D0 publication Critical patent/DK179788D0/da
Publication of DK179788A publication Critical patent/DK179788A/da
Priority to DK200300404A priority Critical patent/DK175244B1/da
Application granted granted Critical
Publication of DK174878B1 publication Critical patent/DK174878B1/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/15Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/04Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Anesthesiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Photolithography (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK198801797A 1987-04-01 1988-03-30 Anvendelse af N-aryl-piperazinalkanamidderivater til fremstilling af et medikament til forbedring af søvn DK174878B1 (da)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DK200300404A DK175244B1 (da) 1987-04-01 2003-03-17 N-aryl-piperazinalkanamidderivater, farmaceutiske sammensætninger indeholdende disse samt fremgangsmåder til fremstilling deraf

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3412987A 1987-04-01 1987-04-01
US3412987 1987-04-01

Publications (3)

Publication Number Publication Date
DK179788D0 DK179788D0 (da) 1988-03-30
DK179788A DK179788A (da) 1988-10-02
DK174878B1 true DK174878B1 (da) 2004-01-12

Family

ID=21874492

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198801797A DK174878B1 (da) 1987-04-01 1988-03-30 Anvendelse af N-aryl-piperazinalkanamidderivater til fremstilling af et medikament til forbedring af søvn

Country Status (21)

Country Link
EP (2) EP0727421B1 (de)
JP (1) JP2574377B2 (de)
KR (1) KR960016539B1 (de)
AT (2) ATE142627T1 (de)
AU (1) AU609790B2 (de)
CA (1) CA1315790C (de)
DE (2) DE3855520T2 (de)
DK (1) DK174878B1 (de)
ES (2) ES2167510T3 (de)
FI (1) FI97617C (de)
GR (1) GR3020983T3 (de)
HK (1) HK1006020A1 (de)
HU (2) HUT57740A (de)
IE (1) IE81057B1 (de)
IL (1) IL85919A (de)
NO (1) NO178660C (de)
NZ (1) NZ223847A (de)
PH (1) PH25507A (de)
PT (1) PT87118B (de)
RU (1) RU2014328C1 (de)
ZA (1) ZA882352B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU632888B2 (en) * 1989-11-22 1993-01-14 Janssen Pharmaceutica N.V. Use of piperazine acetamide derivatives against reperfusion damage
US5840896A (en) * 1989-11-22 1998-11-24 Janssen Pharmaceutica, N.V. Method of preventing or limiting reperfusion damage
JP2660086B2 (ja) * 1990-07-03 1997-10-08 明治製菓株式会社 脳及び心機能障害改善剤
US5276035A (en) * 1990-07-26 1994-01-04 Novo Nordisk A/S 1,4-disubstituted piperazines
DK0582164T3 (da) * 1992-07-31 1999-08-23 Bristol Myers Squibb Co Adenosin-genoptagelsesinhiberende derivater af diphenyloxazoler, -thiazoler og -imidazoler
SE9202266D0 (sv) * 1992-07-31 1992-07-31 Kabi Pharmacia Ab Novel piperazine carboxamides
US5856485A (en) * 1994-04-20 1999-01-05 Lonza Ag Process for preparing 2-piperazinecarboxylic acid derivatives
EP0870502A3 (de) * 1997-04-10 2001-04-04 Kyowa Hakko Kogyo Co., Ltd. Verwendung von Adenosinaufnahmeinhibitoren zur Herstellung eines Arzneimittels zur Behandlung von Pankreatitis
DE69814089T2 (de) 1997-06-16 2004-02-19 Janssen Pharmaceutica N.V. Verwendung von einem draflazin analog zur schmerzbehandlung
UA89503C2 (uk) 2004-09-13 2010-02-10 Х. Луннбек А/С Заміщені похідні аніліну
WO2006074025A1 (en) 2004-12-30 2006-07-13 Janssen Pharmaceutica N.V. Piperazinyl and piperidinyl ureas as modulators of fatty acid amide hydrolase
UA108233C2 (uk) 2010-05-03 2015-04-10 Модулятори активності гідролази амідів жирних кислот
CN110511220B (zh) * 2018-05-22 2022-04-01 上海挚盟医药科技有限公司 作为钾通道调节剂的对二氨基苯衍生物、其制备方法及其在医药上的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1795375A1 (de) * 1968-09-21 1972-01-05 Boehringer Mannheim Gmbh Basische AEther und Verfahren zur Herstellung derselben
US4766125A (en) * 1981-06-23 1988-08-23 Janssen Pharmaceutica N.V. N-aryl-piperazinealkanamides useful for protecting hearts from myocardial injury caused by ischaemia, anoxia or hypoxia

Also Published As

Publication number Publication date
JPS63290869A (ja) 1988-11-28
DK179788A (da) 1988-10-02
EP0285219A2 (de) 1988-10-05
GR3020983T3 (en) 1996-12-31
NO178660B (no) 1996-01-29
EP0285219A3 (de) 1991-07-03
HU211129A9 (en) 1995-10-30
NO881407D0 (no) 1988-03-29
PT87118A (pt) 1988-04-01
IL85919A0 (en) 1988-09-30
ZA882352B (en) 1989-12-27
FI97617B (fi) 1996-10-15
EP0285219B1 (de) 1996-09-11
DK179788D0 (da) 1988-03-30
DE3855520D1 (de) 1996-10-17
NZ223847A (en) 1989-12-21
HUT57740A (en) 1991-12-30
IE81057B1 (en) 1999-12-29
RU2014328C1 (ru) 1994-06-15
IE880989L (en) 1988-10-01
DE3856501T2 (de) 2004-04-29
ES2167510T3 (es) 2002-05-16
KR880012566A (ko) 1988-11-28
PT87118B (pt) 1992-07-31
AU1384788A (en) 1988-10-06
AU609790B2 (en) 1991-05-09
HK1006020A1 (en) 1999-02-05
FI881525A0 (fi) 1988-03-31
KR960016539B1 (ko) 1996-12-14
EP0727421B1 (de) 2001-10-24
IL85919A (en) 1992-12-01
DE3856501D1 (de) 2001-11-29
JP2574377B2 (ja) 1997-01-22
EP0727421A1 (de) 1996-08-21
DE3855520T2 (de) 1997-02-06
FI97617C (fi) 1997-01-27
FI881525A (fi) 1988-10-02
NO178660C (no) 1996-05-08
ATE207474T1 (de) 2001-11-15
NO881407L (no) 1988-10-03
CA1315790C (en) 1993-04-06
ES2091183T3 (es) 1996-11-01
PH25507A (en) 1991-07-24
ATE142627T1 (de) 1996-09-15

Similar Documents

Publication Publication Date Title
DK174878B1 (da) Anvendelse af N-aryl-piperazinalkanamidderivater til fremstilling af et medikament til forbedring af søvn
DE3248160A1 (de) 2-(4-((4,4-dialkyl-2,6-piperidindion-1-yl)-butyl)-1-piperazinyl)pyrimidine, verfahren zu ihrer herstellung und pharmazeutische mittel, die diese verbindungen enthalten
EP0006506A1 (de) 1,2-Dihydro-chinolin-2-on-Derivate, Verfahren zu deren Herstellung sowie diese Verbindungen enthaltende Arzneimittel
DE2461604A1 (de) 8-hydroxy-3,4-dihydrocarbostyril- derivate, verfahren zu ihrer herstellung und arzneimittel
EP0212481B1 (de) Indolinonderivate, Verfahren zu ihrer Herstellung, sie enthaltende Arzneimittel und deren Verwendung
DD201305A5 (de) Verfahren zur herstellung von in 7-stellung substituierten benzopyranen
PL90025B1 (de)
DE69329084T2 (de) Benzoxazepin-Derivate als Cholinesterase-Inhibitoren
DD145104B3 (de) Verfahren zur herstellung von polyalkoxyphenylpyrrolidone
US5576327A (en) Treatment of heart rhythym disorders by administration of 3-phenylsulfonyl-3, 7-diazabicyclo[3.3.1]nonane compounds
US4547514A (en) Aryloxy-N-(aminoalkyl)-1-pyrrolidine and piperidine carboxamides and carbothioamides having antiarrhythmic activity
DE3424586A1 (de) 3-aminocarbonylmethoxy-5-phenyl-pyrazol-verbindungen sowie verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
EP0027928B1 (de) Piperidinderivate von 4,5-Dialkyl-3-hydroxy-pyrrol-2-carbonsäureestern, ihre Herstellung und diese enthaltende pharmazeutische Zubereitungen
US4259334A (en) Piperazines and therapeutic utility
EP0219898B1 (de) Alpha,alpha-diaryl-4-aryl-4-hydroxy-1-piperidin-butanamid-N-Oxide
CS214841B2 (en) Method of making the tetrahydrochinolines
JPS5872584A (ja) 新規キサンチン誘導体、その製法ならびに抗アレルギ−剤
EP0038936B1 (de) Neue 1-Aryloxy-3-alkylamino-2-propanole und Verfahren zu ihrer Herstellung
EP0030688B1 (de) Piperidinderivate von 3-Hydroxy-thiophen-2-carbonsäureestern, ihre Herstellung und diese enthaltende pharmazeutische Zubereitungen
EP0212216A1 (de) Dihydrochinolinon-Derivate, Verfahren zu ihrer Herstellung, sie enthaltende Arzneimittel und deren Verwendung, sowie Zwischenprodukte zu ihrer Herstellung
JPS60136557A (ja) 置換2―ヒドロキシ―プロピオフェノンのアミノプロパノール誘導体、その製法及び抗不整脈剤
US4442120A (en) 1-Aryloxy-3-alkylamino-propan-2-ols
DE3876338T2 (de) 1-substituierte alkyl-2-oxo-1,2-dihydrochinoxalinderivate.
EP0061709A1 (de) 5,6-Dihydro-11-alkylen-morphantridin-6-one, ihre Herstellung und diese enthaltende Arzneimittel
EP0043971B1 (de) Indanon-oxyalkyl-piperazinderivate, ihre Herstellung und diese enthaltende pharmazeutische Zubereitungen

Legal Events

Date Code Title Description
PUP Patent expired